Connexin Therapeutics
PrivateLast Round
Seed
Feb 8, 2022
Company Overview
Connexin Therapeutics operates in Healthcare & Life Sciences and is based in York. Its latest recorded funding round was a Seed round in February 2022.
Connexin Therapeutics is a biotechnology company that discovers and develops novel drugs to protect retinal neurons and prevent blindness in patients with glaucoma and related ophthalmic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Connexin Therapeutics Comparables
Compare Connexin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InflammX Therapeutics | 81% | |
| Galimedix Therapeutics | 72% | |
| ONL Therapeutics | 72% |
For institutional investors. Book with your work email.
Connexin Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 394% MoM.
- Apr 4, 2026
Monthly visitors grew 206% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Connexin Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Connexin Therapeutics's valuation, stock price, and market status.
Is Connexin Therapeutics a public or private company?
Connexin Therapeutics is a private company.
What is the current stock price of Connexin Therapeutics?
Connexin Therapeutics is a private company, so its shares have no public market price. Caplight tracks Connexin Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Connexin Therapeutics worth (valuation)?
Valuation information for Connexin Therapeutics is not publicly available.
Can I buy Connexin Therapeutics stock?
Connexin Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Connexin Therapeutics's last funding round?
Connexin Therapeutics's most recent funding round was Seed on February 8, 2022.
Who are the main investors in Connexin Therapeutics?
Investor information for Connexin Therapeutics is not publicly disclosed.
Will Connexin Therapeutics IPO soon?
No public IPO plans have been announced for Connexin Therapeutics.
How can I track Connexin Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Connexin Therapeutics's shares on secondary markets.